Taylor Vitreoretinal Center
Pharmaceutical ManufacturingNorth Carolina, United States2-10 Employees
Taylor Vitreoretinal Center is a Pharmaceuticals company located in 1212 Cedarhurst Dr, Raleigh, North Carolina, United States.
Niche Market Focus As a specialized vitreoretinal healthcare provider with a small team, Taylor Vitreoretinal Center likely serves a localized patient base, presenting opportunities to offer tailored medical devices, surgical equipment, and ophthalmic pharmaceuticals suited for retinal care.
Growth Potential The company's modest revenue indicates room for expansion, suggesting opportunities to introduce innovative retinal treatment solutions or enhance existing product lines to support their clinical services and attract more patients.
Competitive Landscape Operating in a market with large ophthalmology groups generating significantly higher revenues, Taylor Vitreoretinal Center could benefit from partnerships or supply agreements with device manufacturers aiming to penetrate smaller or specialized clinics.
Technology Adoption With limited information on their tech stack, engaging the company in technologically advanced diagnostic tools, minimally invasive surgical instruments, or digital health solutions could enhance their service offerings and operational efficiency.
Regional Expansion Located in Raleigh, North Carolina, the company presents a strategic opportunity for regional outreach initiatives, expanding patient access through new clinics or telemedicine collaborations supported by innovative pharmaceutical or equipment vendors.
| Taylor Vitreoretinal Center Email Formats | Percentage |
| FLast@taylorretinacenter.com | 57% |
| First.Last@taylorretinacenter.com | 43% |
Pharmaceutical ManufacturingNorth Carolina, United States2-10 Employees
Taylor Vitreoretinal Center is a Pharmaceuticals company located in 1212 Cedarhurst Dr, Raleigh, North Carolina, United States.
Taylor Vitreoretinal Center's revenue is estimated to be in the range of $1M
Taylor Vitreoretinal Center's revenue is estimated to be in the range of $1M